DESIGN THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.62 USD | +2.84% |
|
-0.82% | +36.60% |
| 03-20 | Sector Update: Health Care Stocks Ease Late Afternoon | MT |
| 03-20 | Sector Update: Health Care Stocks Down Wednesday Afternoon | MT |
Chart calendar Design Therapeutics, Inc.
6a2f1b.hb52Lw93kmiBF7z_7CBq8bW_NmX9rCNcaMGzyi_bfsI.4d0PXk0z3jrPW-mzgnMsxNbmdwvEyFkOMbXkiE7pTrDu809CZyjWMOBkiA~0d343e2393dbc9610560fc3777c0a8df
Upcoming events on Design Therapeutics, Inc.
Past events on Design Therapeutics, Inc.
| 2024-03-19 16:30 | Q4 2023 Earnings Call |
| 2024-03-19 16:01 | Q4 2023 Earnings Release |
| 2023-11-13 16:05 | Q3 2023 Earnings Release |
| 2023-08-14 16:30 | DT-216 Phase 1 Clinical Trial Results Call |
| 2023-08-14 16:05 | Q2 2023 Earnings Release |
| 2023-06-07 15:30 | Jefferies Global Healthcare Conference |
| 2023-05-30 | Annual General Meeting |
| 2023-05-09 16:05 | Q1 2023 Earnings Release |
| 2023-03-14 16:05 | Q4 2022 Earnings Release |
| 2023-02-15 17:00 | SVB Securities Global Biopharma Conference |
| 2022-12-07 16:30 | DT-216 Phase 1 SAD Trial Results Call |
| 2022-11-03 16:05 | Q3 2022 Earnings Release |
| 2022-11-03 10:15 | International Congress for Ataxia Research Conference |
| 2022-09-29 15:30 | Jefferies Cell and Genetic Medicine Summit - Fireside Chat |
| 2022-08-10 10:20 | Wedbush PacGrow Healthcare Conference |
| 2022-08-07 | Interim 2022 Earnings Release (Projected) |
| 2022-06-15 11:30 | Annual General Meeting |
| 2022-06-08 08:30 | Jefferies Healthcare Conference |
| 2022-05-18 09:30 | RBC Capital Markets Global Healthcare Conference |
| 2022-05-09 16:05 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -35,7 -38,4 6.95% | -67,2 -67,9 1.11% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -35,8 -37,4 4.17% | -67,6 -67,5 -0.18% | -78,2 -83,1 5.92% | -76,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -35,5 -36,1 1.61% | -63,3 -64,4 1.65% | -66,9 -74,1 9.74% | -87,5 |
|
Net income Million USD | Released Forecast Spread | -8,28 | -35,5 -36,5 2.54% | -63,3 -65,3 3.02% | -66,9 -73,0 8.43% | -73,1 |
|
EPS USD | Released Forecast Spread | -0,52 | -0,77 -0,83 7.23% | -1,14 -1,17 2.29% | -1,19 -1,30 8.7% | -1,27 |
| Announcement Date | 05/03/21 | 10/03/22 | 14/03/23 | 19/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,1 -12,7 12.29% | -13,4 -12,3 -8.73% | -15,6 -13,9 -12.42% | -19,2 -16,4 -17.24% | -19,4 -19,3 -0.64% | -21,7 -20,3 -6.41% | -22,6 -22,5 -0.46% | -18,8 -23,8 21.05% | -15,1 -20,0 24.56% | -16,9 | -18,3 | -19,7 | -21,4 | -26,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,1 -11,6 5.01% | -13,3 -12,3 -7.83% | -15,0 -13,9 -7.58% | -17,7 -15,7 -13.11% | -17,3 -18,4 5.76% | -19,3 -20,4 5.21% | -19,9 -22,5 11.36% | -15,8 -23,0 31.21% | -11,8 -19,1 37.85% | -17,9 | -20,6 | -23,2 | -25,7 | -26,0 |
|
Net income Million USD | Released Forecast Spread | -11,1 -12,0 7.59% | -13,3 -12,1 -9.62% | -15,0 -14,1 -6.17% | -17,7 -15,6 -13.24% | -17,3 -19,3 10.16% | -19,3 -20,7 6.65% | -19,9 -22,9 13.05% | -15,8 -23,8 33.57% | -11,8 -18,0 34.22% | -16,1 | -17,6 | -19,0 | -20,5 | -26,0 |
|
EPS USD | Released Forecast Spread | -0,20 -0,22 6.98% | -0,24 -0,22 -11.63% | -0,27 -0,25 -6.58% | -0,32 -0,28 -14.29% | -0,31 -0,34 9.71% | -0,35 -0,37 4.55% | -0,36 -0,41 12.2% | -0,28 -0,42 33.33% | -0,21 -0,32 33.68% | -0,28 | -0,31 | -0,33 | -0,35 | -0,43 |
| Announcement Date | 10/03/22 | 09/05/22 | 08/08/22 | 03/11/22 | 14/03/23 | 09/05/23 | 14/08/23 | 13/11/23 | 19/03/24 | - | - | - | - | - |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-01 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
Past sector events for Design Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DSGN Stock
- Calendar Design Therapeutics, Inc.
